Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
66.6M
-
Number of holders
-
27
-
Total 13F shares, excl. options
-
1.55M
-
Shares change
-
-6.63M
-
Total reported value, excl. options
-
$3.66M
-
Value change
-
-$15.6M
-
Number of buys
-
23
-
Number of sells
-
-4
-
Price
-
$2.36
Significant Holders of TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) as of Q4 2017
29 filings reported holding TNDM - TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share as of Q4 2017.
TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) has 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.55M shares
of 66.6M outstanding shares and own 2.33% of the company stock.
Largest 10 shareholders include FRONTIER CAPITAL MANAGEMENT CO LLC (473K shares), WASATCH ADVISORS INC (279K shares), TPG Group Holdings (SBS) Advisors, Inc. (250K shares), Alyeska Investment Group, L.P. (139K shares), JACOBS LEVY EQUITY MANAGEMENT, INC (78.9K shares), BlackRock Inc. (42K shares), UBS Group AG (38K shares), Ausdal Financial Partners, Inc. (29.7K shares), WEDBUSH SECURITIES INC (29.5K shares), and SABBY MANAGEMENT, LLC (27.5K shares).
This table shows the top 27 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.